The acquisition of SuppCo by Function in May marks a significant development in the burgeoning health and wellness industry, aiming to bridge the critical gap between product quality and individual efficacy. This move, spearheaded by industry veteran Robert DeuPree, founder and CEO of Reverse Age Lab, signals a potential paradigm shift where consumers are treated as individuals rather than mere transaction points. While companies like Examine, ConsumerLab, and Labdoor have established themselves as crucial resources for research and independent testing, DeuPree argues that even the highest quality supplement can be ineffective if it’s not the right product for the individual.
DeuPree’s extensive 15-year tenure as CEO of Sunfood Superfoods, a company he successfully scaled to be present in major retail chains like Whole Foods, Sprouts, and Walmart, provides him with a unique vantage point. His experience underscores the significant costs associated with true quality in supplement manufacturing. This includes rigorous sourcing with traceable origins, comprehensive laboratory testing, and meticulously compliant labeling that accurately reflects product contents. DeuPree highlights that a substantial portion of the industry circumvents these costly but essential practices.
The rationale behind Function’s acquisition of SuppCo is rooted in this acknowledgment of industry shortcomings. SuppCo’s own internal testing initiatives have revealed a stark reality: approximately half of leading supplements fail basic label accuracy checks. This data aligns with external reports, such as ConsumerLab’s findings earlier this spring, which indicated that one in three multivitamins failed their rigorous testing protocols. The ability to provide a "supplement quality score," as Function and SuppCo now offer, is presented as a valuable tool for consumers navigating a complex marketplace. Such scores inherently reward manufacturers who invest in quality control and ethical production, a move DeuPree believes he would have welcomed as a manufacturer himself.
The Limits of Quality Scores: Addressing the Individual
Despite the undeniable value of a quality score, DeuPree emphasizes its inherent limitations. A perfectly manufactured supplement, he asserts, can be entirely useless for a specific individual. The disconnect often arises from the extrapolation of research findings. Studies frequently focus on a particular ingredient, at a specific dosage, within a defined population – sometimes even conducted on animal models. The supplement bottle on the shelf, however, may contain a significantly lower dose, and the consumer purchasing it might bear little resemblance to the study participants, possessing unique health considerations or pre-existing conditions that necessitate a different approach.
"Twelve mice and a randomized human trial get the same weight in the marketing copy, and quite often in the chatbot answer too," DeuPree notes, illustrating the common practice of leveraging even limited research to bolster product claims. This highlights a crucial area where quality scores fall short: they cannot ascertain whether a product is right for an individual or if it will truly work for them.
Furthermore, the current landscape of supplement consumption often overlooks the complex interplay of an individual’s entire regimen. Many "stacks," or combinations of supplements, are assembled piecemeal, often influenced by trending podcast discussions or YouTube videos, with little regard for potential interactions or redundancies. DeuPree points out the common scenario of individuals unknowingly taking multiple products containing the same ingredient, or worse, unknowingly combining supplements that could interact negatively with prescribed medications. A blood pressure medication, for instance, might be taken alongside something it should not interact with, or an individual might repurchase a supplement they already possess simply because they’ve lost track of their inventory.
The Unspoken Business Model: Perpetual Consumption
A particularly poignant observation from DeuPree concerns the industry’s inherent disincentive to advise consumers on when to cease supplement use. "The industry has no economic interest in that sentence," he states plainly. The business model, as he experienced firsthand, is built on expansion, not contraction. Growth is achieved by introducing new products and encouraging consumers to add them to their routines, not by recommending that they stop taking existing ones. This fundamental economic reality has historically prevented brands from offering comprehensive guidance that might lead to reduced supplement consumption.
The implication of this business model is that consumers are often left to navigate their supplement choices in a vacuum, with the onus of determining suitability and optimal usage falling solely on them. This is where the limitations of a purely quality-focused approach become most apparent.
Beyond the Bottle: The Rise of Personalized Protocols
In response to these industry-wide gaps, DeuPree founded Reverse Age Lab. This venture is dedicated to providing the critical layer of personalized guidance that he believes is missing. When a consumer approaches him seeking advice, DeuPree doesn’t simply point to a quality score. Instead, he offers a series of probing questions that the score cannot answer, questions that delve into the individual’s unique circumstances.
"None of that is on the label. None of it is in a manufacturing audit. All of it decides whether the money was well spent," DeuPree emphasizes. He elaborates that truly personalized recommendations require a holistic view of the individual: their health goals, dietary habits, exercise routines, all current supplements, and crucially, their latest blood work. This comprehensive data then needs to be cross-referenced with evidence-based research, with a strict grading system that prioritizes human studies and transparently notes animal research without presenting it as definitive proof. The outcome is a dynamic schedule that adapts as the individual’s needs evolve.
This intensive, personalized approach is a significant undertaking, which explains why the broader industry has historically shied away from it. The absence of a tangible product to sell at the end of such a process has been a significant barrier. In fact, a truly personalized protocol might recommend prioritizing diet and exercise, potentially reducing the need for supplements altogether – a concept antithetical to a business model focused on selling bottles.
Proof of Concept: A Personal Transformation
DeuPree’s own journey serves as a testament to the efficacy of this personalized approach. He reveals that by following the principles he developed after leaving Sunfood Superfoods, his own biological age has been measured at 45, despite being 60 years old. He offers this not as a sales pitch, but as tangible proof that such a system can yield remarkable results.
He posits that companies now building comprehensive health platforms must recognize that the true value for the customer lies "the layer above the quality score." The moment a grader also becomes a seller of the product, the integrity of their assessment is compromised. This is a critical point for the burgeoning health tech sector, which is increasingly offering integrated solutions.
The Function and SuppCo alliance, by bringing together blood testing capabilities with a supplement quality score, represents a positive step. However, DeuPree maintains that this is only the initial phase. "The next step is the plan, built for the individual from the evidence, by someone with nothing to sell them," he asserts. This philosophy is the driving force behind Reverse Age Lab, a service designed to definitively answer the crucial consumer questions: "What should I take, and when?"
The Broader Implications: A New Era for Consumer Health
The acquisition and the subsequent strategic direction signaled by Function and SuppCo, coupled with the independent validation offered by Reverse Age Lab, suggest a potential shift in the supplement industry’s focus. For years, the industry has been characterized by a product-centric approach, emphasizing novel ingredients, impressive marketing claims, and a constant stream of new formulations. This has often left consumers feeling overwhelmed and uncertain about what truly serves their individual health needs.
The move towards integrating diagnostic tools like blood tests with quality assessments acknowledges that a one-size-fits-all approach to supplementation is fundamentally flawed. The data generated from blood tests can reveal specific deficiencies or imbalances, providing a scientific basis for recommending certain nutrients. When this data is combined with a rigorous assessment of supplement quality, it creates a more robust framework for informed decision-making.
However, as DeuPree rightly points out, this is only part of the equation. The efficacy of a supplement is also contingent on individual lifestyle factors, existing medical conditions, and interactions with other substances. The emergence of services like Reverse Age Lab, which explicitly decouple recommendation from sales, offers a crucial counterpoint to the industry’s historical profit motives. By providing unbiased, evidence-based guidance, these services aim to empower consumers to make choices that are truly aligned with their long-term health and well-being.
The challenge for companies like Function and SuppCo will be to evolve beyond simply offering a combined product offering and to embrace a more comprehensive, personalized model. The success of this new approach will ultimately be measured not by the volume of supplements sold, but by the demonstrable improvements in consumer health outcomes. As the health and wellness landscape continues to mature, the emphasis is increasingly shifting from the product itself to the personalized journey of the individual seeking to optimize their health. The acquisition of SuppCo by Function, therefore, is not just a business transaction; it is a potential harbinger of a more intelligent, evidence-driven, and consumer-centric future for the supplement industry. The question remains whether the industry as a whole will embrace this evolution or cling to established, albeit less effective, paradigms.
